Ascentage Pharma Files 2024 Annual Report

Ticker: AAPG · Form: 6-K · Filed: Apr 17, 2025 · CIK: 2023311

Sentiment: neutral

Topics: annual-report, filing

TL;DR

Ascentage Pharma dropped its 2024 20-F and annual report on April 16th.

AI Summary

Ascentage Pharma Group International filed its annual report on Form 20-F for the fiscal year ended December 31, 2024, on April 16, 2025. The company, located at 68 Xinqing Road, Suzhou Industrial Park, China, also published its Annual Report for the fiscal year ended December 31, 2024, on April 16, 2025, Hong Kong Time.

Why It Matters

This filing provides investors with the company's audited financial performance and operational highlights for the past fiscal year, crucial for evaluating its current standing and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine annual report submission and does not contain new material events or financial disclosures that would inherently increase risk.

Key Players & Entities

FAQ

When did Ascentage Pharma Group International file its annual report on Form 20-F?

Ascentage Pharma Group International filed its annual report on Form 20-F for the fiscal year ended December 31, 2024, on April 16, 2025.

What is the fiscal year end for Ascentage Pharma Group International?

The fiscal year end for Ascentage Pharma Group International is December 31.

Where are Ascentage Pharma Group International's principal executive offices located?

The principal executive offices of Ascentage Pharma Group International are located at 68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.

Did Ascentage Pharma Group International publish its Annual Report for the fiscal year ended December 31, 2024?

Yes, on April 16, 2025, Hong Kong Time, the Company published its Annual Report for the fiscal year ended December 31, 2024.

Which form does Ascentage Pharma Group International indicate it files annual reports under?

Ascentage Pharma Group International indicates it files annual reports under Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 17, 2025 regarding ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing